CJC-1295 No DAC.
About CJC-1295 No DAC
CJC-1295 No DAC is among the peptides researched in the context of the growth hormone (GH) axis. Like native GHRH, CJC-1295 without DAC binds GHRH receptors on the pituitary; the four amino acid modifications increase stability against DPP-4 degradation.
Research Application
Studied in GH-axis research as a short-acting GHRH variant that, unlike the DAC-conjugated form, is intended to allow more pulsatile rather than sustained receptor stimulation.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
- Teichman SL, et al. J Clin Endocrinol Metab. 2006;91(3):799–805. PMID 16352683
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Question about CJC-1295 No DAC?
We reply personally – via email or Telegram.